Aurinia Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.
CEOPeter S. Greenleaf
CEOPeter S. Greenleaf
Employees300
Employees300
HeadquartersEdmonton, Alberta
HeadquartersEdmonton, Alberta
Founded1993
Founded1993
Employees300
Employees300
AUPH Key Statistics
Market cap736.11M
Market cap736.11M
Price-Earnings ratio-9.34
Price-Earnings ratio-9.34
Dividend yield—
Dividend yield—
Average volume1.33M
Average volume1.33M
High today—
High today—
Low today—
Low today—
Open price$5.02
Open price$5.02
Volume0.00
Volume0.00
52 Week high$12.43
52 Week high$12.43
52 Week low$4.71
52 Week low$4.71
AUPH News
Seeking Alpha 6d
Aurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024 - Seeking AlphaEditor's note: Seeking Alpha is proud to welcome Pivotal Biotech as a new contributing analyst. You can become one too! Share your best investment idea by submi...
Analyst ratings
63%
of 8 ratingsBuy
62.5%
Hold
37.5%
Sell
0%